Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew L. Posard currently holds 69,874 shares of HALOZYME THERAPEUTICS INC (HALO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew L. Posard has been a net seller of HALO stock. They have purchased $2.2M and sold $7.4M worth of shares.
Matthew L. Posard's most recent insider trade was on Aug 14, 2024, when they sold 9,881 shares at $57.70 per share.
Matthew L. Posard serves as Executive at HALOZYME THERAPEUTICS INC (HALO). They have executed 63 insider transactions totaling $9.6M over their tenure at the company.
Matthew L. Posard holds the position of Executive at HALOZYME THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Matthew L. Posard has shown a selling trading pattern, with $2.2M in total purchases and $7.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew L. Posard was on Feb 17, 2021, when they purchased $1.0M worth of TLIS shares. This transaction involved 62,500 shares at $16.00 per share.
Matthew L. Posard currently owns 69,874 shares of HALOZYME THERAPEUTICS INC (HALO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew L. Posard's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew L. Posard has 63 Form 4 filings on record as an insider at HALOZYME THERAPEUTICS INC.
Set alerts for Matthew L. Posard and 40,000+ other insiders.